Opposing roles of the triggering receptor expressed on myeloid cells 2 and triggering receptor expressed on myeloid cells-like transcript 2 in microglia activation

Neurobiology of Aging

Volumn 42, Issue , 2016, Pages 132-141

  Zheng, Honghua ^a   Liu, Chia Chen ^b   Atagi, Yuka ^b   Chen, Xiao Fen ^a   Jia, Lin ^a   Yang, Longyu ^a   He, Wencan ^a   Zhang, Xilin ^a   Kang, Silvia S ^b   Rosenberry, Terrone L ^b   Fryer, John D ^b,c   Zhang, Yun Wu ^a,d   Xu, Huaxi ^a,d   Bu, Guojun ^a,b,c  

^a XIAMEN UNIVERSITY   (China)

^b MAYO GRADUATE SCHOOL   (United States)

^c MAYO CLINIC   (United States)

^d BURNHAM INSTITUTE   (United States)

Author keywords

Inflammation; Microglia; Proliferation; TREM2; TREML2

Indexed keywords

AMYLOID BETA PROTEIN; CYTOKINE; LIPOPOLYSACCHARIDE; TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 2; TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS LIKE TRANSCRIPT 2; UNCLASSIFIED DRUG; IMMUNOGLOBULIN RECEPTOR; MEMBRANE PROTEIN; TREM2 PROTEIN, MOUSE; TREML2 PROTEIN, HUMAN;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE RESPONSE; DOWN REGULATION; IN VIVO STUDY; INFLAMMATION; INNATE IMMUNITY; MICROGLIA; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; UPREGULATION; ANIMAL; APOPTOSIS; BRAIN; C57BL MOUSE; CELL CULTURE; GENE EXPRESSION; GENETICS; IMMUNOLOGY; METABOLISM; MOLECULARLY TARGETED THERAPY; MUTATION; PATHOLOGY; PHYSIOLOGY;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; APOPTOSIS; BRAIN; CELLS, CULTURED; CYTOKINES; DOWN-REGULATION; GENE EXPRESSION; IMMUNITY, INNATE; LIPOPOLYSACCHARIDES; MEMBRANE GLYCOPROTEINS; MICE, INBRED C57BL; MICROGLIA; MOLECULAR TARGETED THERAPY; MUTATION; RECEPTORS, IMMUNOLOGIC; UP-REGULATION;

EID: 84962792128     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2016.03.004     Document Type: Article

References (48)

1. Aguzzi A., Barres B.A., Bennett M.L. Microglia: scapegoat, saboteur, or something else?. Science 2013, 339:156-161.
2. Benitez B.A., Cruchaga C. TREM2 and neurodegenerative disease. N. Engl. J. Med. 2013, 369:1567-1568.
3. Benitez B.A., Jin S.C., Guerreiro R., Graham R., Lord J., Harold D., Sims R., Lambert J.C., Gibbs J.R., Bras J., Sassi C., Harari O., Bertelsen S., Lupton M.K., Powell J., Bellenguez C., Brown K., Medway C., Haddick P.C., van der Brug M.P., Bhangale T., Ortmann W., Behrens T., Mayeux R., Pericak-Vance M.A., Farrer L.A., Schellenberg G.D., Haines J.L., Turton J., Braae A., Barber I., Fagan A.M., Holtzman D.M., Morris J.C., Williams J., Kauwe J.S., Amouyel P., Morgan K., Singleton A., Hardy J., Goate A.M., Cruchaga C. Missense variant in TREML2 protects against Alzheimer's disease. Neurobiol. Aging 2014, 35:1510.e19-1510.e26.
4. Block M.L., Zecca L., Hong J.S. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat. Rev. Neurosci. 2007, 8:57-69.
5. Colonna M. TREMs in the immune system and beyond. Nat. Rev. Immunol. 2003, 3:445-453.
6. Ford J.W., McVicar D.W. TREM and TREM-like receptors in inflammation and disease. Curr. Opin. Immunol. 2009, 21:38-46.
7. Frautschy S.A., Yang F., Irrizarry M., Hyman B., Saido T.C., Hsiao K., Cole G.M. Microglial response to amyloid plaques in APPsw transgenic mice. Am. J. Pathol. 1998, 152:307-317.
8. Gao X., Dong Y., Liu Z., Niu B. Silencing of triggering receptor expressed on myeloid cells-2 enhances the inflammatory responses of alveolar macrophages to lipopolysaccharide. Mol. Med. Rep. 2013, 7:921-926.
9. Guerreiro R., Hardy J. TREM2 and neurodegenerative disease. N. Engl. J. Med. 2013, 369:1569-1570.
10. Guerreiro R., Wojtas A., Bras J., Carrasquillo M., Rogaeva E., Majounie E., Cruchaga C., Sassi C., Kauwe J.S., Younkin S., Hazrati L., Collinge J., Pocock J., Lashley T., Williams J., Lambert J.C., Amouyel P., Goate A., Rademakers R., Morgan K., Powell J., St George-Hyslop P., Singleton A., Hardy J. TREM2 variants in Alzheimer's disease. N. Engl. J. Med. 2013, 368:117-127. Alzheimer Genetic Analysis, G.
11. Hamerman J.A., Jarjoura J.R., Humphrey M.B., Nakamura M.C., Seaman W.E., Lanier L.L. Cutting edge: inhibition of TLR and FcR responses in macrophages by triggering receptor expressed on myeloid cells (TREM)-2 and DAP12. J. Immunol. 2006, 177:2051-2055.
12. Heneka M.T., Carson M.J., El Khoury J., Landreth G.E., Brosseron F., Feinstein D.L., Jacobs A.H., Wyss-Coray T., Vitorica J., Ransohoff R.M., Herrup K., Frautschy S.A., Finsen B., Brown G.C., Verkhratsky A., Yamanaka K., Koistinaho J., Latz E., Halle A., Petzold G.C., Town T., Morgan D., Shinohara M.L., Perry V.H., Holmes C., Bazan N.G., Brooks D.J., Hunot S., Joseph B., Deigendesch N., Garaschuk O., Boddeke E., Dinarello C.A., Breitner J.C., Cole G.M., Golenbock D.T., Kummer M.P. Neuroinflammation in Alzheimer's disease. Lancet Neurol. 2015, 14:388-405.
13. Hsieh C.L., Koike M., Spusta S.C., Niemi E.C., Yenari M., Nakamura M.C., Seaman W.E. A role for TREM2 ligands in the phagocytosis of apoptotic neuronal cells by microglia. J. Neurochem. 2009, 109:1144-1156.
14. Huang D., Zimmerman M.I., Martin P.K., Nix A.J., Rosenberry T.L., Paravastu A.K. Antiparallel beta-sheet structure within the C-Terminal region of 42-Residue Alzheimer's amyloid-beta peptides when they form 150-kDa oligomers. J. Mol. Biol. 2015, 427:2319-2328.
15. Ito H., Hamerman J.A. TREM-2, triggering receptor expressed on myeloid cell-2, negatively regulates TLR responses in dendritic cells. Eur. J. Immunol. 2012, 42:176-185.
16. Jay T.R., Miller C.M., Cheng P.J., Graham L.C., Bemiller S., Broihier M.L., Xu G., Margevicius D., Karlo J.C., Sousa G.L., Cotleur A.C., Butovsky O., Bekris L., Staugaitis S.M., Leverenz J.B., Pimplikar S.W., Landreth G.E., Howell G.R., Ransohoff R.M., Lamb B.T. TREM2 deficiency eliminates TREM2+ inflammatory macrophages and ameliorates pathology in Alzheimer's disease mouse models. J. Exp. Med. 2015, 212:287-295.
17. Jiang T., Yu J.T., Zhu X.C., Tan L. TREM2 in Alzheimer's disease. Mol. Neurobiol. 2013, 48:180-185.
18. Jiang T., Yu J.T., Zhu X.C., Tan M.S., Gu L.Z., Zhang Y.D., Tan L. Triggering receptor expressed on myeloid cells 2 knockdown exacerbates aging-related neuroinflammation and cognitive deficiency in senescence-accelerated mouse prone 8 mice. Neurobiol. Aging 2014, 35:1243-1251.
19. Jonsson T., Stefansson H., Steinberg S., Jonsdottir I., Jonsson P.V., Snaedal J., Bjornsson S., Huttenlocher J., Levey A.I., Lah J.J., Rujescu D., Hampel H., Giegling I., Andreassen O.A., Engedal K., Ulstein I., Djurovic S., Ibrahim-Verbaas C., Hofman A., Ikram M.A., van Duijn C.M., Thorsteinsdottir U., Kong A., Stefansson K. Variant of TREM2 associated with the risk of Alzheimer's disease. N. Engl. J. Med. 2013, 368:107-116.
20. Kettenmann H., Hanisch U.K., Noda M., Verkhratsky A. Physiology of microglia. Physiol. Rev. 2011, 91:461-553.
21. King R.G., Herrin B.R., Justement L.B. Trem-like transcript 2 is expressed on cells of the myeloid/granuloid and B lymphoid lineage and is up-regulated in response to inflammation. J. Immunol. 2006, 176:6012-6021.
22. Klesney-Tait J., Turnbull I.R., Colonna M. The TREM receptor family and signal integration. Nat. Immunol. 2006, 7:1266-1273.
23. Landel V., Baranger K., Virard I., Loriod B., Khrestchatisky M., Rivera S., Benech P., Feron F. Temporal gene profiling of the 5XFAD transgenic mouse model highlights the importance of microglial activation in Alzheimer's disease. Mol. Neurodegener. 2014, 9:33.
24. Lawson L.J., Perry V.H., Dri P., Gordon S. Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain. Neuroscience 1990, 39:151-170.
25. Lee C.Y., Landreth G.E. The role of microglia in amyloid clearance from the AD brain. J. Neural. Transm. 2010, 117:949-960.
26. Liu W., Brosnan C.F., Dickson D.W., Lee S.C. Macrophage colony-stimulating factor mediates astrocyte-induced microglial ramification in human fetal central nervous system culture. Am. J. Pathol. 1994, 145:48-53.
27. Mitrasinovic O.M., Murphy G.M. Accelerated phagocytosis of amyloid-beta by mouse and human microglia overexpressing the macrophage colony-stimulating factor receptor. J. Biol. Chem. 2002, 277:29889-29896.
28. Monif M., Burnstock G., Williams D.A. Microglia: proliferation and activation driven by the P2X7 receptor. Int. J. Biochem. Cell Biol. 2010, 42:1753-1756.
29. Mosher K.I., Wyss-Coray T. Microglial dysfunction in brain aging and Alzheimer's disease. Biochem. Pharmacol. 2014, 88:594-604.
30. N'Diaye E.N., Branda C.S., Branda S.S., Nevarez L., Colonna M., Lowell C., Hamerman J.A., Seaman W.E. TREM-2 (triggering receptor expressed on myeloid cells 2) is a phagocytic receptor for bacteria. J. Cell Biol. 2009, 184:215-223.
31. Neumann H., Takahashi K. Essential role of the microglial triggering receptor expressed on myeloid cells-2 (TREM2) for central nervous tissue immune homeostasis. J. Neuroimmunol. 2007, 184:92-99.
32. Nimmrich V., Ebert U. Is Alzheimer's disease a result of presynaptic failure? Synaptic dysfunctions induced by oligomeric beta-amyloid. Rev. Neurosci. 2009, 20:1-12.
33. Otero K., Shinohara M., Zhao H., Cella M., Gilfillan S., Colucci A., Faccio R., Ross F.P., Teitelbaum S.L., Takayanagi H., Colonna M. TREM2 and beta-catenin regulate bone homeostasis by controlling the rate of osteoclastogenesis. J. Immunol. 2012, 188:2612-2621.
34. Painter M.M., Atagi Y., Liu C.C., Rademakers R., Xu H., Fryer J.D., Bu G. TREM2 in CNS homeostasis and neurodegenerative disease. Mol. Neurodegener. 2015, 10:43.
35. Peng Q., Malhotra S., Torchia J.A., Kerr W.G., Coggeshall K.M., Humphrey M.B. TREM2- and DAP12-dependent activation of PI3K requires DAP10 and is inhibited by SHIP1. Sci. Signal. 2010, 3:ra38.
36. Perlmutter L.S., Barron E., Chui H.C. Morphologic association between microglia and senile plaque amyloid in Alzheimer's disease. Neurosci. Lett. 1990, 119:32-36.
37. Polazzi E., Monti B. Microglia and neuroprotection: from in vitro studies to therapeutic applications. Prog. Neurobiol. 2010, 92:293-315.
38. Ransohoff R.M., Perry V.H. Microglial physiology: unique stimuli, specialized responses. Annu. Rev. Immunol. 2009, 27:119-145.
39. Rossi S., Motta C., Studer V., Macchiarulo G., Volpe E., Barbieri F., Ruocco G., Buttari F., Finardi A., Mancino R., Weiss S., Battistini L., Martino G., Furlan R., Drulovic J., Centonze D. Interleukin-1beta causes excitotoxic neurodegeneration and multiple sclerosis disease progression by activating the apoptotic protein p53. Mol. Neurodegener. 2014, 9:56.
40. Stefano L., Racchetti G., Bianco F., Passini N., Gupta R.S., Panina Bordignon P., Meldolesi J. The surface-exposed chaperone, Hsp60, is an agonist of the microglial TREM2 receptor. J. Neurochem. 2009, 110:284-294.
41. Streit W.J. Microglia and Alzheimer's disease pathogenesis. J. Neurosci. Res. 2004, 77:1-8.
42. Sun M., Zhu M., Chen K., Nie X., Deng Q., Hazlett L.D., Wu Y., Li M., Wu M., Huang X. TREM-2 promotes host resistance against Pseudomonas aeruginosa infection by suppressing corneal inflammation via a PI3K/Akt signaling pathway. Invest. Ophthalmol. Vis. Sci. 2013, 54:3451-3462.
43. Takahashi K., Prinz M., Stagi M., Chechneva O., Neumann H. TREM2-transduced myeloid precursors mediate nervous tissue debris clearance and facilitate recovery in an animal model of multiple sclerosis. PLoS Med. 2007, 4:e124.
44. Takahashi K., Rochford C.D., Neumann H. Clearance of apoptotic neurons without inflammation by microglial triggering receptor expressed on myeloid cells-2. J. Exp. Med. 2005, 201:647-657.
45. Tu S., Okamoto S., Lipton S.A., Xu H. Oligomeric abeta-induced synaptic dysfunction in Alzheimer's disease. Mol. Neurodegener. 2014, 9:48.
46. Turnbull I.R., Gilfillan S., Cella M., Aoshi T., Miller M., Piccio L., Hernandez M., Colonna M. Cutting edge: TREM-2 attenuates macrophage activation. J. Immunol. 2006, 177:3520-3524.
47. Wang Y., Cella M., Mallinson K., Ulrich J.D., Young K.L., Robinette M.L., Gilfillan S., Krishnan G.M., Sudhakar S., Zinselmeyer B.H., Holtzman D.M., Cirrito J.R., Colonna M. TREM2 lipid sensing sustains the microglial response in an Alzheimer's disease model. Cell 2015, 160:1061-1071.
48. Zhu W., Zheng H., Shao X., Wang W., Yao Q., Li Z. Excitotoxicity of TNFalpha derived from KA activated microglia on hippocampal neurons in vitro and in vivo. J. Neurochem. 2010, 114:386-396.